Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Arachidonoyl-Specific Diacylglycerol Kinase ε and the Endoplasmic Reticulum.

Nakano T, Matsui H, Tanaka T, Hozumi Y, Iseki K, Kawamae K, Goto K.

Front Cell Dev Biol. 2016 Nov 18;4:132. Review.

2.

Cloning and Characterization of Novel Testis-Specific Diacylglycerol Kinase η Splice Variants 3 and 4.

Murakami E, Shionoya T, Komenoi S, Suzuki Y, Sakane F.

PLoS One. 2016 Sep 19;11(9):e0162997. doi: 10.1371/journal.pone.0162997.

3.

Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An Update.

Sakane F, Mizuno S, Komenoi S.

Front Cell Dev Biol. 2016 Aug 17;4:82. doi: 10.3389/fcell.2016.00082. Review.

4.

Diacylglycerol kinases in membrane trafficking.

Xie S, Naslavsky N, Caplan S.

Cell Logist. 2015 Aug 3;5(2):e1078431. Review.

5.

The Pleckstrin Homology Domain of Diacylglycerol Kinase η Strongly and Selectively Binds to Phosphatidylinositol 4,5-Bisphosphate.

Kume A, Kawase K, Komenoi S, Usuki T, Takeshita E, Sakai H, Sakane F.

J Biol Chem. 2016 Apr 8;291(15):8150-61. doi: 10.1074/jbc.M115.648717.

PMID:
26887948
6.

A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.

Liu K, Kunii N, Sakuma M, Yamaki A, Mizuno S, Sato M, Sakai H, Kado S, Kumagai K, Kojima H, Okabe T, Nagano T, Shirai Y, Sakane F.

J Lipid Res. 2016 Mar;57(3):368-79. doi: 10.1194/jlr.M062794.

7.

Distinct expression and localization of the type II diacylglycerol kinase isozymes δ, η and κ in the mouse reproductive organs.

Shionoya T, Usuki T, Komenoi S, Isozaki T, Sakai H, Sakane F.

BMC Dev Biol. 2015 Jan 23;15:6. doi: 10.1186/s12861-015-0055-z.

8.

Expression and localization of type II diacylglycerol kinase isozymes δ and η in the developing mouse brain.

Usuki T, Sakai H, Shionoya T, Sato N, Sakane F.

J Histochem Cytochem. 2015 Jan;63(1):57-68. doi: 10.1369/0022155414559130.

9.
10.

Diacylglycerol kinase as a possible therapeutic target for neuronal diseases.

Shirai Y, Saito N.

J Biomed Sci. 2014 Apr 7;21:28. doi: 10.1186/1423-0127-21-28. Review.

11.

Diacylglycerol kinases: regulated controllers of T cell activation, function, and development.

Joshi RP, Koretzky GA.

Int J Mol Sci. 2013 Mar 26;14(4):6649-73. doi: 10.3390/ijms14046649. Review.

12.

Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).

Crotty TM, Nakano T, Stafforini DM, Topham MK.

J Biol Chem. 2013 Jan 18;288(3):1439-47. doi: 10.1074/jbc.M112.407379.

13.

Biosynthesis of alkyl lysophosphatidic acid by diacylglycerol kinases.

Gellett AM, Kharel Y, Sunkara M, Morris AJ, Lynch KR.

Biochem Biophys Res Commun. 2012 Jun 15;422(4):758-63. doi: 10.1016/j.bbrc.2012.05.077.

14.

Zinc binding drives sheet formation by the SAM domain of diacylglycerol kinase δ.

Knight MJ, Joubert MK, Plotkowski ML, Kropat J, Gingery M, Sakane F, Merchant SS, Bowie JU.

Biochemistry. 2010 Nov 9;49(44):9667-76. doi: 10.1021/bi101261x.

15.

Diacylglycerol kinase delta and protein kinase C(alpha) modulate epidermal growth factor receptor abundance and degradation through ubiquitin-specific protease 8.

Cai J, Crotty TM, Reichert E, Carraway KL 3rd, Stafforini DM, Topham MK.

J Biol Chem. 2010 Mar 5;285(10):6952-9. doi: 10.1074/jbc.M109.055731.

16.

Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization.

Yasuda S, Kai M, Imai S, Takeishi K, Taketomi A, Toyota M, Kanoh H, Sakane F.

J Biol Chem. 2009 Oct 23;284(43):29559-70. doi: 10.1074/jbc.M109.043604.

17.

Mammalian diacylglycerol kinases: molecular interactions and biological functions of selected isoforms.

Topham MK, Epand RM.

Biochim Biophys Acta. 2009 Jun;1790(6):416-24. doi: 10.1016/j.bbagen.2009.01.010. Review.

18.

Diacylglycerol kinases as sources of phosphatidic acid.

Cai J, Abramovici H, Gee SH, Topham MK.

Biochim Biophys Acta. 2009 Sep;1791(9):942-8. doi: 10.1016/j.bbalip.2009.02.010. Review.

19.

Diacylglycerol kinases in immune cell function and self-tolerance.

Zhong XP, Guo R, Zhou H, Liu C, Wan CK.

Immunol Rev. 2008 Aug;224:249-64. doi: 10.1111/j.1600-065X.2008.00647.x. Review.

20.

Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17.

Li D, Urs AN, Allegood J, Leon A, Merrill AH Jr, Sewer MB.

Mol Cell Biol. 2007 Oct;27(19):6669-85.

Supplemental Content

Support Center